OMRF

Research Technician II/Research Technician III

Job Locations US-OK-Oklahoma City
ID
2023-1555
Category
Laboratory
Status
Full-Time

Overview

Founded in 1946, the Oklahoma Medical Research Foundation (OMRF) is among the nation’s oldest, most respected independent, nonprofit biomedical research institutes. OMRF is dedicated to understanding and developing more effective treatments for human diseases, focusing on critical research areas such as Alzheimer’s disease, cancer, lupus, Multiple Sclerosis, and cardiovascular disease. OMRF follows an innovative cross-disciplinary approach to medical research and ranks among the nation’s leaders in patents per scientist.

 

Located in Oklahoma City, a city that offers a dynamic and flourishing downtown area, with low cost of living, short commute times and a diversified economy, OMRF has been voted one of the Top Workplaces since the inception of the award. This achievement has been accomplished thanks to OMRF individuals who share a unified understanding that our excellence can only be fully realized with a commitment to diversity, equity, and inclusion. Successful candidates will demonstrate commitment to these values.

 

Benefits
We offer competitive salaries and comprehensive benefits including, medical, dental, and vision insurance, minimum 8% company retirement contribution, vacation and sick leave, paid holidays, onsite café, free onsite fitness center with access to personal trainer, free parking and much more! Relocation assistance available for those located 50 miles outside of Oklahoma City metro and out of state. Learn more about our benefits here.


OMRF is an Equal Opportunity/Affirmative Action/Veterans Employer. All qualified applicants will receive consideration for employment without regard to gender, sexual orientation, gender identity, race, color, national origin, age, religion, disability, veteran status, or any other legally protected characteristic.

Responsibilities

The Guthridge & James labs (james.omrf.org; Guthridge.omrf.org) are seeking a highly motivated and organized individual to contribute to projects designed to deconstruct the drivers of autoimmune disease at the molecular level in both preclinical and advanced disease states. Studies characterizing the immune cells and their responses against pathogens and autoreactive responses at the cellular and tissue levels using advanced single-cell multiomic phenotyping approaches, high-dimnensional biomarker profiling, and spatial multiomic techniques. Duties will include both basic and advanced cell and molecular biology techniques, such as Luminex and Olink biomarker assays in addition to ELISAs, Western blotting. Single cell techniques including multi-parameter flow cytometry, high-dimensional mass cytometry (CyTOF), imaging mass cytometry (Hyperion), and single cell transcriptomics, proteomics and repertoire using the latest 10X genomics platforms.

Minimum Qualifications

Bachelor’s degree typically in one of the biological sciences and/or equivalent years of relevant laboratory experience.


Must have effective communication skills and excellent attention to detail. Must be motivated, conscientious, and highly dependable. Must be able to read and comprehend instructions, short correspondence and protocols/procedures, and to write routine reports and correspondence. Should be familiar with standard lab techniques. Must be able to work with minimal instruction on routine work.

Preferred Qualifications

Strong GPA and interest in biomedical research. Hands-on experience with laboratory techniques (histology, imaging/microscopy, flow cytometry, and molecular techniques)  highly preferred. Candidates interested in pursuing graduate school or medical school are welcome to apply.

 

Familiarity with Windows Office (Word, Excel, PowerPoint, and Access), robotics, image analysis such as ImageJ, Halo, Visiopharm, and other digital pathology systems, data analytics and data visualization using R and Python, or other software such as Prism is preferred.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed